DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Zee Learn Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·12 Oct 2026, 3:08 pm

ZEE Learn

Zee Learn Limited has informed the stock exchanges that it has received a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory filing confirms that the company has successfully met the necessary compliance requirements related to its shareholding structure and depository processes.

This development is generally viewed as a routine administrative update that reinforces the company's adherence to market regulations. For investors, it serves as a confirmation of good corporate governance and transparency in the management of shareholding data. It does not signal any new operational changes or financial results, but it provides assurance regarding the company's compliance status.

Investors should monitor the company's future disclosures for any updates on its financial performance or strategic initiatives. As this is a standard regulatory filing, it is not expected to have a direct impact on the stock's valuation in the short term.